MCC’s Mission & History
Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement.
Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.
Linda Sullivan (Co-Founder & President)
Linda has the day-to-day experience and expertise that provides excellence, stability and growth for our organization. She has been the motivating force behind MCC’s continuing growth since 2006. Her duties include direct membership/dues-based services and ongoing operations of the company.
Ken Getz (Owner & Advisor)
Ken provides unparalleled opportunities for MCC membership growth due to his myriad industry connections, track record in investing and growing companies, and acknowledged industry leadership. He provides assistance and insight in market, membership, product and service development.
Dave Zuckerman (Owner & Advisor)
Dave Zuckerman is the world’s leading expert in pharmaceutical R&D standardized performance metrics, has worked with and consulted for MCC, and has successfully led metrics development and consulting efforts across the industry. He supports the MCC with new product development, the MCC Benchmarking Database and MCC Education.